Last reviewed · How we verify
NCT05939401: ANCABio
A Study Regarding Tissue Response During and After Treatment for Anal Cancer
trial testing Biopsies in Anal Cancer in 400 participants. Currently enrolling.
1 December 2027
Quick facts
| Lead sponsor | Sahlgrenska University Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 December 2023 |
| Primary completion | 1 December 2027 |
| Estimated completion | 1 December 2029 |
| Sites | 2 locations across Sweden |
Drugs / interventions tested
- Biopsies — full drug profile →
Conditions studied
- Anal Cancer — all drugs for Anal Cancer →
Sponsor
Sahlgrenska University Hospital
Who can join
18 and older, any sex, with Anal Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to improve the understanding for the tumour biology in relation to treatment response in patients with anal cancer by examining: * The tumour microenvironment * The localisation of and cellular interactions between the tumour and immune cells * The gene and protein expression by cells present in the tumour and surrounding tissue.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05939401
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Biopsies
Trials testing the same drug.
- NCT07292454 — Prevalence of Helicobacter Pylori on Patients With Chronic Inflammatory Bowel Disease (IBD) at the CHU of Guadeloupe · not yet recruiting
- NCT06656923 — Analyze Previously Collected Biopsy Samples From Participants Who Completed the "SPLASH: Split-Body Randomized Clinical · active not recruiting
- NCT05798962 — Cellular Mechanisms Involved in Muscle Pathology · recruiting
- NCT04820959 — Validation of New Therapeutic Targets to Prevent Collagen Accumulation During Cardiac Fibrosis: Procollagen C-proteinase · NA · completed
- NCT04556929 — Enhanced Detection in Glioma Excision · NA · terminated
Other recruiting trials for Anal Cancer
Currently open trials in the same condition.
- NCT07192055 — Self-sampling to Optimize Anal Lesion Outcomes · NA · recruiting
- NCT07296237 — Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer · recruiting
- NCT07124000 — DESTINY-PANTUMOUR04 · recruiting
- NCT05639972 — E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · Phase 1, PHASE2 · recruiting
- NCT06670495 — HPV Genotype Attribution and Disease Burden of Anal Cancer in China · recruiting
Other Sahlgrenska University Hospital trials
Trials by the same sponsor.
- NCT07491094 — Repeated Examinations for Typing Pulmonary Embolism · recruiting
- NCT07524608 — Implementing an Evidence-based, Standardized Care Bundle Targeting Register Nurses and Anaesthesiologists, to Enhance Pa · not yet recruiting
- NCT07498959 — Primary RPLND Versus Systemic Chemotherapy in Good-prognosis Metastatic Testicular Cancer · NA · recruiting
- NCT06896578 — Latitude - Lateral Lymph Node Attitude Study · NA · not yet recruiting
- NCT07035600 — Walking and Sitting Difficulties After Rectal Cancer Surgery · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05939401 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sahlgrenska University Hospital
- Last refreshed: 18 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05939401.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing